The Private Equity team has advised Gyrus Capital on its acquisition of LRE Medical, a leading provider of complex devices and analytical instruments for the life sciences industry, from AIS Global.
Headquartered in Nördlingen, Germany, LRE Medical supports its global customer base through a comprehensive service offering providing high-quality engineering solutions and manufacturing for medical and life science diagnostic equipment.
The carve-out represents a central pillar of Gyrus Capital's investment strategy. Completion of the transaction is expected in the third quarter of 2023 and is subject to customary regulatory approvals.
The acquisition was led by head of private equity Ian Piggin, supported by senior associate Chelsie Taylor and banking partner Alasdair McKenzie who led the debt finance.
Commenting on the acquisition, Ian said: "This is an exciting partnership for Gyrus Capital that will allow LRE Medical to enhance its offering and deliver sustainable growth. I am excited to see how the business develops following this transaction and the benefits it will bring to the healthcare sector."
Dr Robert Watson, partner at Gyrus Capital, added: "We are grateful to the team at Gowling WLG for ensuring a seamless process for this acquisition and delivering a deal that benefits all parties involved. This is an exciting time to partner with the LRE Medical management team following the recent announcement of the Chancellor's growth package for the UK's life sciences sector and we look forward to supporting the company's future growth."
Gowling WLG works with businesses, intellectual property, human resource and regulatory teams to provide guidance and support in key areas of life sciences – from protecting and enforcing ideas, clinical trial protocols, the drafting of clinical trial agreements and drug submissions to licensing, financing, employment and labour issues, resolving contractual disputes, research and development (R&D), pricing, reimbursement and more.